• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢病毒载体的生物安全性特征。

Biosafety features of lentiviral vectors.

机构信息

Institute of Experimental Hematology, Hannover Medical School, D-30625 Hannover, Germany.

出版信息

Hum Gene Ther. 2013 Feb;24(2):132-42. doi: 10.1089/hum.2012.229.

DOI:10.1089/hum.2012.229
PMID:23311447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3581032/
Abstract

Over the past decades, lentiviral vectors have evolved as a benchmark tool for stable gene transfer into cells with a high replicative potential. Their relatively flexible genome and ability to transduce many forms of nondividing cells, combined with the potential for cell-specific pseudotyping, provides a rich resource for numerous applications in experimental platforms and therapeutic settings. Here, we give an overview of important biosafety features of lentiviral vectors, with detailed discussion of (i) the principles of the lentiviral split-genome design used for the construction of packaging cells; (ii) the relevance of modifications introduced into the lentiviral long terminal repeat (deletion of enhancer/promoter sequences and introduction of insulators); (iii) the basic features of mRNA processing, including the Rev/Rev-responsive element (RRE) interaction and the modifications of the 3' untranslated region of lentiviral vectors with various post-transcriptional regulatory elements affecting transcriptional termination, polyadenylation, and differentiation-specific degradation of mRNA; and (iv) the characteristic integration pattern with the associated risk of transcriptional interference with cellular genes. We conclude with considerations regarding the importance of cell targeting via envelope modifications. Along this course, we address canonical biosafety issues encountered with any type of viral vector: the risks of shedding, mobilization, germline transmission, immunogenicity, and insertional mutagenesis.

摘要

在过去的几十年中,慢病毒载体已发展成为将基因稳定转入具有高复制潜能的细胞的基准工具。其相对灵活的基因组和转导多种非分裂细胞的能力,加上细胞特异性假型化的潜力,为实验平台和治疗环境中的许多应用提供了丰富的资源。在这里,我们概述了慢病毒载体的重要生物安全特性,并详细讨论了(i)用于构建包装细胞的慢病毒分裂基因组设计的原理;(ii)引入慢病毒长末端重复序列中的修饰(增强子/启动子序列的缺失和绝缘子的引入);(iii)mRNA 加工的基本特征,包括 Rev/Rev 反应元件(RRE)相互作用以及各种转录后调控元件对慢病毒载体 3'非翻译区的修饰,影响转录终止、多聚腺苷酸化和 mRNA 的分化特异性降解;和(iv)特征性整合模式以及与细胞基因转录干扰相关的风险。最后,我们考虑了通过包膜修饰进行细胞靶向的重要性。在此过程中,我们解决了任何类型的病毒载体都会遇到的典型生物安全问题:脱落、移动、种系传播、免疫原性和插入突变的风险。

相似文献

1
Biosafety features of lentiviral vectors.慢病毒载体的生物安全性特征。
Hum Gene Ther. 2013 Feb;24(2):132-42. doi: 10.1089/hum.2012.229.
2
Production of lentiviral vectors for transducing cells from the central nervous system.用于转导中枢神经系统细胞的慢病毒载体的生产。
J Vis Exp. 2012 May 24(63):e4031. doi: 10.3791/4031.
3
Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors.提高自失活γ-逆转录病毒和慢病毒载体的转录终止效率。
Mol Ther. 2007 Jun;15(6):1167-73. doi: 10.1038/sj.mt.6300152. Epub 2007 Apr 3.
4
Progress in lentiviral vector technologies.慢病毒载体技术的进展。
Hum Gene Ther. 2013 Feb;24(2):117-8. doi: 10.1089/hum.2013.2500.
5
Gene delivery by lentivirus vectors.慢病毒载体介导的基因递送
Mol Biotechnol. 2007 Jul;36(3):184-204. doi: 10.1007/s12033-007-0010-8.
6
Self-inactivating lentiviral vectors with U3 and U5 modifications.具有U3和U5修饰的自失活慢病毒载体。
Virology. 1999 Aug 15;261(1):120-32. doi: 10.1006/viro.1999.9850.
7
Biosafety challenges for use of lentiviral vectors in gene therapy.慢病毒载体在基因治疗中的生物安全性挑战。
Curr Gene Ther. 2013 Dec;13(6):453-68. doi: 10.2174/15665232113136660006.
8
Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: expression and potential for helper virus-free packaging.用于基因转移的2型人类免疫缺陷病毒慢病毒载体:表达及无辅助病毒包装的潜力。
Hum Gene Ther. 1998 Jun 10;9(9):1371-80. doi: 10.1089/hum.1998.9.9-1371.
9
Robust Enhancement of Lentivirus Production by Promoter Activation.通过启动子激活增强慢病毒生产。
Sci Rep. 2018 Oct 11;8(1):15036. doi: 10.1038/s41598-018-33042-5.
10
A self-deletion lentiviral vector to reduce the risk of replication-competent virus formation.一种自我删除慢病毒载体,可降低形成复制型病毒的风险。
J Gene Med. 2013 Feb;15(2):102-12. doi: 10.1002/jgm.2700.

引用本文的文献

1
Alternative transcription increases isoform complexity in Long Non-Coding RNAs and alters their functions in cancer.可变转录增加了长链非编码RNA的异构体复杂性,并改变了它们在癌症中的功能。
Noncoding RNA Res. 2025 May 3;14:38-50. doi: 10.1016/j.ncrna.2025.04.008. eCollection 2025 Oct.
2
Development of a novel pseudovirus-based quality control material for HIV-1 nucleic acid testing and its application in external quality assessment.一种用于HIV-1核酸检测的新型基于假病毒的质量控制材料的开发及其在外部质量评估中的应用。
Microbiol Spectr. 2025 Jul;13(7):e0026925. doi: 10.1128/spectrum.00269-25. Epub 2025 Jun 10.
3
PD-L1 and ICAM1 over expression empowers immunoregulation of mesenchymal stromal cells to improve the autoimmune hepatitis treatment efficacy.程序性死亡受体配体1(PD-L1)和细胞间黏附分子1(ICAM1)的过表达增强了间充质基质细胞的免疫调节作用,从而提高自身免疫性肝炎的治疗效果。
Stem Cell Res Ther. 2025 Apr 24;16(1):209. doi: 10.1186/s13287-025-04347-w.
4
Utilizing shRNA-expressing lentivectors for viral hemorrhagic septicemia virus suppression via NV gene targeting.利用表达短发夹RNA的慢病毒载体通过靶向NV基因抑制病毒性出血性败血症病毒。
Front Vet Sci. 2025 Apr 4;12:1508470. doi: 10.3389/fvets.2025.1508470. eCollection 2025.
5
Facilitating Gene Editing in Human Lymphoma Cells Using Murine Ecotropic γ-Retroviruses.利用鼠嗜亲性γ-逆转录病毒促进人类淋巴瘤细胞中的基因编辑
Methods Mol Biol. 2025;2909:133-151. doi: 10.1007/978-1-0716-4442-3_10.
6
Optimized gene transduction in human lung organoids: A high-efficiency method for advanced research applications.人肺类器官中优化的基因转导:一种用于高级研究应用的高效方法。
Commun Biol. 2025 Feb 3;8(1):164. doi: 10.1038/s42003-025-07461-w.
7
The design of retroviral vectors used in the CAR-T products, risk management, and future perspective.嵌合抗原受体T细胞(CAR-T)产品中使用的逆转录病毒载体设计、风险管理及未来展望。
MedComm (2020). 2025 Jan 24;6(2):e70067. doi: 10.1002/mco2.70067. eCollection 2025 Feb.
8
The Modulation of Fibrosis in Vocal Fold Repair: A Study on c-Met Agonistic Antibodies and Hepatocyte Growth in Animal Studies.声带修复中纤维化的调节:关于c-Met激动性抗体和肝细胞生长因子在动物研究中的一项研究。
Medicina (Kaunas). 2024 Dec 10;60(12):2033. doi: 10.3390/medicina60122033.
9
Eradication of Cancer Cells Using Doxifluridine and Mesenchymal Stem Cells Expressing Thymidine Phosphorylase.使用多西氟尿苷和表达胸苷磷酸化酶的间充质干细胞根除癌细胞。
Bioengineering (Basel). 2024 Nov 26;11(12):1194. doi: 10.3390/bioengineering11121194.
10
mRNA-laden lipid nanoparticle-enabled humanized CD19 CAR-T-cell engineering for the eradication of leukaemic cells.基于负载信使核糖核酸的脂质纳米颗粒的人源化CD19嵌合抗原受体T细胞工程用于清除白血病细胞
Br J Haematol. 2025 Feb;206(2):628-643. doi: 10.1111/bjh.19988. Epub 2025 Jan 6.

本文引用的文献

1
Lentiviral transduction of CD34(+) cells induces genome-wide epigenetic modifications.慢病毒转导 CD34(+)细胞诱导全基因组表观遗传修饰。
PLoS One. 2012;7(11):e48943. doi: 10.1371/journal.pone.0048943. Epub 2012 Nov 7.
2
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies.基于麻疹病毒糖蛋白的慢病毒靶向载体,可避免中和抗体。
PLoS One. 2012;7(10):e46667. doi: 10.1371/journal.pone.0046667. Epub 2012 Oct 10.
3
Multiple roles of the capsid protein in the early steps of HIV-1 infection.衣壳蛋白在 HIV-1 感染早期的多种作用。
Virus Res. 2012 Dec;170(1-2):15-24. doi: 10.1016/j.virusres.2012.09.012. Epub 2012 Oct 3.
4
A TLR and non-TLR mediated innate response to lentiviruses restricts hepatocyte entry and can be ameliorated by pharmacological blockade.TLR 和非 TLR 介导的先天免疫反应限制了慢病毒进入肝细胞,可通过药物阻断加以改善。
Mol Ther. 2012 Dec;20(12):2257-67. doi: 10.1038/mt.2012.150. Epub 2012 Aug 7.
5
Antiviral Mechanism and Biochemical Basis of the Human APOBEC3 Family.人类载脂蛋白B mRNA编辑酶催化多肽样蛋白3(APOBEC3)家族的抗病毒机制及生化基础
Front Microbiol. 2012 Jul 9;3:250. doi: 10.3389/fmicb.2012.00250. eCollection 2012.
6
Safer, silencing-resistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicing.更安全、抗沉默的慢病毒载体:通过消除异常剪接优化普遍存在的染色质开放元件。
J Virol. 2012 Sep;86(17):9088-95. doi: 10.1128/JVI.00485-12. Epub 2012 Jun 13.
7
Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells.展示改良麻疹病毒 gp 的慢病毒载体克服了体内样转导人 T 和 B 细胞中的预先存在的免疫。
Mol Ther. 2012 Sep;20(9):1699-1712. doi: 10.1038/mt.2012.96. Epub 2012 May 22.
8
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts.慢病毒载体在人类基因组中的整合会诱导选择性剪接,并产生异常的转录本。
J Clin Invest. 2012 May;122(5):1653-66. doi: 10.1172/JCI61852. Epub 2012 Apr 23.
9
Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations.慢病毒载体整合诱导的异常剪接事件的全转录组特征分析。
J Clin Invest. 2012 May;122(5):1667-76. doi: 10.1172/JCI62189. Epub 2012 Apr 23.
10
Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia.慢病毒载体诱导的 Ebf1 单等位基因缺失导致小鼠白血病。
Mol Ther. 2012 Jun;20(6):1187-95. doi: 10.1038/mt.2012.59. Epub 2012 Apr 3.